Qu Biologics Initiates Phase 2a Clinical Trial For Non-Small Cell Lung Cancer
Lung Cancer, News
Qu Biologics Inc is a biotechnology company working to develop Site Specific Immunomodulators (SSIs) that are used to re-install the body’s normal immune function in a specific disease organ. The company recently announced that ... Read more